Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 8 | 2020 | 22 | 2.140 |
Why?
|
| Cartilage, Articular | 6 | 2019 | 77 | 1.670 |
Why?
|
| Whole-Body Irradiation | 4 | 2015 | 58 | 1.420 |
Why?
|
| Knee Joint | 3 | 2019 | 151 | 1.380 |
Why?
|
| Weightlessness | 4 | 2020 | 9 | 1.270 |
Why?
|
| Hindlimb Suspension | 4 | 2019 | 11 | 1.270 |
Why?
|
| Gait | 2 | 2019 | 134 | 0.780 |
Why?
|
| Animals | 27 | 2020 | 8544 | 0.720 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 834 | 0.590 |
Why?
|
| Bone and Bones | 5 | 2014 | 99 | 0.560 |
Why?
|
| Hip Joint | 1 | 2019 | 69 | 0.560 |
Why?
|
| Mice | 14 | 2020 | 2691 | 0.540 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2019 | 83 | 0.520 |
Why?
|
| Weight-Bearing | 2 | 2016 | 47 | 0.500 |
Why?
|
| Anus Neoplasms | 1 | 2016 | 13 | 0.500 |
Why?
|
| Femur Neck | 1 | 2016 | 23 | 0.500 |
Why?
|
| Pelvis | 1 | 2016 | 68 | 0.480 |
Why?
|
| Arthritis | 1 | 2016 | 43 | 0.480 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 5 | 0.480 |
Why?
|
| Spasm | 1 | 2016 | 6 | 0.480 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 23 | 0.470 |
Why?
|
| Ribs | 1 | 2016 | 47 | 0.460 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 73 | 0.450 |
Why?
|
| Radiometry | 1 | 2015 | 52 | 0.450 |
Why?
|
| Joints | 1 | 2014 | 12 | 0.430 |
Why?
|
| Angiotensin I | 1 | 2016 | 239 | 0.410 |
Why?
|
| Peptide Fragments | 1 | 2016 | 429 | 0.380 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 568 | 0.380 |
Why?
|
| Radiosurgery | 1 | 2016 | 360 | 0.380 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1118 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 452 | 0.360 |
Why?
|
| Osteogenesis | 3 | 2019 | 81 | 0.340 |
Why?
|
| Bone Density | 4 | 2018 | 208 | 0.330 |
Why?
|
| Male | 14 | 2020 | 20697 | 0.310 |
Why?
|
| Etidronic Acid | 1 | 2009 | 3 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 23 | 0.300 |
Why?
|
| Osteoporosis | 1 | 2009 | 74 | 0.290 |
Why?
|
| Mitochondria | 2 | 2020 | 218 | 0.290 |
Why?
|
| Osteoclasts | 1 | 2008 | 25 | 0.280 |
Why?
|
| Tibia | 4 | 2016 | 61 | 0.270 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 45 | 0.270 |
Why?
|
| Alligators and Crocodiles | 2 | 2005 | 3 | 0.270 |
Why?
|
| Locomotion | 2 | 2005 | 37 | 0.260 |
Why?
|
| Rats | 3 | 2016 | 1946 | 0.250 |
Why?
|
| Glycosaminoglycans | 3 | 2016 | 23 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 984 | 0.250 |
Why?
|
| Cell Proliferation | 1 | 2008 | 628 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 152 | 0.210 |
Why?
|
| Tail | 1 | 2004 | 5 | 0.210 |
Why?
|
| Time Factors | 2 | 2019 | 2352 | 0.210 |
Why?
|
| Femur | 3 | 2016 | 82 | 0.200 |
Why?
|
| Pesticides | 1 | 2016 | 201 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 237 | 0.200 |
Why?
|
| Osteoarthritis | 2 | 2014 | 80 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 248 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 304 | 0.190 |
Why?
|
| Swine | 4 | 2019 | 230 | 0.190 |
Why?
|
| Chondrocytes | 2 | 2013 | 70 | 0.190 |
Why?
|
| Oxidative Stress | 2 | 2020 | 265 | 0.180 |
Why?
|
| Punctures | 2 | 2019 | 35 | 0.180 |
Why?
|
| Hindlimb | 2 | 2016 | 55 | 0.170 |
Why?
|
| Protons | 2 | 2012 | 23 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2020 | 60 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 52 | 0.160 |
Why?
|
| Proteome | 1 | 2020 | 41 | 0.160 |
Why?
|
| Genomics | 1 | 2020 | 94 | 0.160 |
Why?
|
| Spacecraft | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2016 | 948 | 0.160 |
Why?
|
| Adaptation, Ocular | 1 | 2019 | 4 | 0.150 |
Why?
|
| Extremities | 1 | 2019 | 55 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 123 | 0.150 |
Why?
|
| Organ Size | 2 | 2018 | 236 | 0.150 |
Why?
|
| Blood-Retinal Barrier | 1 | 2019 | 5 | 0.150 |
Why?
|
| Osteoblasts | 2 | 2019 | 44 | 0.150 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 44 | 0.150 |
Why?
|
| Menisci, Tibial | 1 | 2019 | 24 | 0.150 |
Why?
|
| Female | 8 | 2019 | 21490 | 0.150 |
Why?
|
| Retina | 1 | 2019 | 86 | 0.140 |
Why?
|
| Amnion | 1 | 2019 | 37 | 0.140 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 68 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 44 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 21 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 183 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 113 | 0.130 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 44 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 126 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 593 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 526 | 0.130 |
Why?
|
| Humans | 9 | 2020 | 34474 | 0.120 |
Why?
|
| Middle Aged | 4 | 2017 | 12703 | 0.120 |
Why?
|
| Body Weight | 2 | 2016 | 343 | 0.120 |
Why?
|
| Macaca mulatta | 1 | 2018 | 355 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 168 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 435 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 118 | 0.120 |
Why?
|
| Rib Fractures | 1 | 2016 | 21 | 0.120 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.120 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 110 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 157 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 10 | 0.120 |
Why?
|
| Radiobiology | 1 | 2015 | 5 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 57 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 1386 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2015 | 44 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 100 | 0.120 |
Why?
|
| Weightlessness Simulation | 1 | 2015 | 1 | 0.120 |
Why?
|
| Oncostatin M | 1 | 2015 | 2 | 0.120 |
Why?
|
| Particle Accelerators | 1 | 2015 | 7 | 0.120 |
Why?
|
| Fibrosis | 1 | 2016 | 129 | 0.110 |
Why?
|
| Reference Values | 1 | 2016 | 265 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2016 | 86 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2015 | 56 | 0.110 |
Why?
|
| Research | 1 | 2015 | 88 | 0.110 |
Why?
|
| Collagen | 1 | 2016 | 239 | 0.110 |
Why?
|
| Random Allocation | 1 | 2016 | 257 | 0.110 |
Why?
|
| Adult | 3 | 2016 | 10015 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 924 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 508 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 91 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2014 | 18 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 808 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 498 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 612 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2015 | 106 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 153 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 923 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 5 | 0.100 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Brain | 1 | 2020 | 1031 | 0.100 |
Why?
|
| Aged | 4 | 2019 | 10998 | 0.100 |
Why?
|
| Fibronectins | 1 | 2013 | 40 | 0.100 |
Why?
|
| X-Rays | 2 | 2013 | 7 | 0.100 |
Why?
|
| Proteoglycans | 1 | 2012 | 37 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 87 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2013 | 765 | 0.090 |
Why?
|
| Cell Survival | 1 | 2012 | 304 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 4150 | 0.090 |
Why?
|
| DNA | 1 | 2012 | 235 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 887 | 0.080 |
Why?
|
| Cosmic Radiation | 1 | 2009 | 13 | 0.080 |
Why?
|
| Humerus | 1 | 2009 | 31 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 115 | 0.070 |
Why?
|
| Rabbits | 2 | 2019 | 231 | 0.070 |
Why?
|
| Apoptosis | 2 | 2020 | 400 | 0.070 |
Why?
|
| Cell Line | 2 | 2019 | 476 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2019 | 484 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 22 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 47 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 54 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2019 | 849 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 426 | 0.050 |
Why?
|
| Cytokines | 1 | 2004 | 269 | 0.050 |
Why?
|
| Radiography | 2 | 2018 | 397 | 0.040 |
Why?
|
| North Carolina | 1 | 2016 | 1612 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 86 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 76 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 50 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 67 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 201 | 0.040 |
Why?
|
| Smell | 1 | 2020 | 47 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 83 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 113 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2019 | 9 | 0.040 |
Why?
|
| Ecological Systems, Closed | 1 | 2019 | 1 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| United States | 2 | 2019 | 4267 | 0.040 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Crystallins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2019 | 33 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 28 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 70 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 44 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 25 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 41 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2019 | 36 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 128 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 118 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 260 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 106 | 0.040 |
Why?
|
| Needles | 1 | 2018 | 33 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 217 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 203 | 0.030 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2018 | 24 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 480 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 102 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 335 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 197 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 2 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 6 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2015 | 44 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 110 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 257 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2019 | 700 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2013 | 10 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 57 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 4136 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3812 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3618 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 96 | 0.020 |
Why?
|
| Synchrotrons | 1 | 2008 | 3 | 0.020 |
Why?
|
| Sunlight | 1 | 2008 | 18 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 52 | 0.020 |
Why?
|
| Electromyography | 1 | 2005 | 68 | 0.010 |
Why?
|